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Abstract: Background and Objectives: Health anxiety is one of the most common problems in patients 
with coronary artery disease. The present study tested whether health anxiety severity could be 
predicted by spiritual well-being and hope in patients with advanced coronary artery disease. Ma-
terials and Methods: In a cross-sectional study, 100 patients with advanced coronary artery disease 
were recruited from hospitals and healthcare centers in Iran. Patients completed self-report scales, 
including the Spiritual Well-Being Scale, Adult Hope Scale, and Short Health Anxiety Inventory. 
Hierarchical multiple regression analyses were used to empirically explore the relations among var-
iables. Results: Results indicated that patients who reported higher levels of hope (β = 0.42, p < 0.01) 
and spiritual well-being (β = 0.20, p < 0.05) reported lower levels of health anxiety. Agency (β = 0.58, 
p < 0.01) scores were a significant negative predictor of health anxiety severity. Additionally, reli-
gious spirituality scores (β = 0.28, p < 0.01) were shown to significantly negatively predict health 
anxiety level. However, the pathways components of hope and existential spirituality were not sig-
nificant predictors. Conclusion: The findings of the present study indicate that spiritual well-being 
and hope could be important factors in determining health anxiety for adults with coronary artery 
disease, and their role is worthy of further exploration to help improve health anxiety for patients 
with coronary artery disease. 




Coronary artery disease (CAD), also known as ischemic heart disease, is the most 
common of the cardiovascular diseases. CAD is caused by a buildup of plaque on the 
walls of arteries that supply blood to the heart and other parts of the body. Despite sig-
nificant advances in the diagnosis and treatment of this disease, it is still one of the leading 
causes of death worldwide [1]. In the United States and Canada, more than 6% of adults 
older than 20 years of age have CAD as the most common form of cardiovascular disease 
[2]. Epidemiological studies in Iran also show that CAD is one of the leading causes of 
death and disability of individuals. The Iranian Ministry of Health and Medical Education 
(MOHME) reported that 39.03% of all deaths in Iran are due to CAD [3]. Most studies on 
the role of psychological factors in heart diseases have confirmed the relationship between 
psychological factors such as emotional distress and cardiovascular disease [4]. Psycho-
logical distress is more prevalent and severe in patients with CAD than in healthy indi-
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viduals [5]. There is evidence indicating that the course of the disease and its complica-
tions, along with the need for invasive procedures in some cases, leads to psychological 
problems such as anxiety in patients. Anxiety is one of the most common psychological 
reactions to cardiovascular disease [6,7]. Moreover, it is one of the significant psychologi-
cal symptoms with an estimated prevalence of 20–50% in adults with CAD [8]. In other 
words, anxiety is a comorbidity in CAD patients [9], and its symptoms are present in most 
of the patients. One type of anxiety that may manifest itself in chronic medical conditions, 
such as coronary heart disease, is health anxiety. 
Health anxiety is worrying about physical symptoms believed to indicate a serious 
illness [10,11]. Health anxiety is a continuum with mild worries about physical sensations 
at one end and severe worries of health and mental occupation with physical sensations 
at the other end [12]. It can occur at any time during the life of a person with CAD. Re-
search suggests that health anxiety is significantly associated with severe clinical condi-
tions [13]. For example, research has shown that children and adolescents with Congenital 
Heart Defects (CHDs) experience high levels of health anxiety compared to normal chil-
dren and adolescents [14]. Another study found that individuals with CHD experience 
health anxiety [15]. Numerous psychological factors, including spiritual well-being, can 
affect health anxiety in patients with coronary heart disease. 
Spiritual well-being is defined as a sense of connection with others, having meaning 
and purpose in life, and believing in and relating to a superior or higher power [16]. Spir-
itual well-being has two dimensions: religious and existential well-being. Religious well-
being is one’s relationship with God and religion, while existential well-being is related 
to one’s mental well-being regarding the meaning and purpose of life, as well as life sat-
isfaction [17]. Although there is no research examining the predictive role of spiritual well-
being in the health anxiety of patients with CAD, several studies have examined the role 
of spiritual well-being in the context of life-threatening illnesses. For example, one study 
investigated the relationship between spiritual well-being and its components with death 
anxiety in a group of elderly people during the COVID-19 pandemic, and the results 
showed that spiritual and religious well-being predicted death anxiety in these individu-
als [18]. Another study showed that with decreasing spiritual well-being scores, depres-
sion, anxiety, and stress increase in patients with heart failure and in family caregivers 
[19]. On the other hand, research shows that hope plays an important role in reducing 
anxiety in people with coronary heart disease. 
Hope is a kind of thought process and consists of two components of agency (pur-
poseful wills) and pathways (purposeful plans), both of which are necessary in the for-
mation and determination of hope through purposeful behaviors. Agency is the motivat-
ing component of hope and reflects a personal perception of the ability to achieve past, 
present, and future goals. The pathway is a cognitive component of hope and reflects an 
individual’s ability to create sensible ways to achieve goals [20]. Hope can be considered 
as an active and dynamic state of existential coping among patients with life-threatening 
illness. The role of hope in the level of health anxiety of patients with CAD has not been 
studied, and most studies have addressed the role of hope in anxiety, depression, and 
adjustment of patients. One study investigated the relation between hope, anxiety and 
health-related quality of life in a number of children and adolescents with cancer, and the 
results showed that there was a positive relation between hope and health-related quality 
of life [21]. Hope was directly and indirectly associated with reduced anxiety in children 
and adolescents with cancer [21]. Research evidence also shows that there is a relation 
between hope and life satisfaction, psychological adjustment, and coping strategies in pa-
tients with spinal cord injury [22]. In a cross-sectional study, the relation between hope 
and anxiety was examined in a group of patients who had heart surgery; there was a neg-
ative and significant relation between life expectancy and anxiety in these patients [23]. In 
another study, the association between hope and anxiety in individuals with advanced 
heart disease was investigated, and the results indicated that hope had a negative corre-
lation with anxiety in these patients [9].  




A review of the literature indicates that previous studies have paid less attention to 
the predictive role of spiritual well-being and hope in the health anxiety of coronary heart 
disease patients, especially in Iran, as a religious country where spirituality and religious 
concepts can play an important role in helping individuals deal with the disease and 
health anxiety; however, the role of these variables in the health anxiety of CAD patients 
is not clear. In order to overcome the gap in the research area and the necessity and im-
portance of identifying the variables of spiritual well-being and hope in the health anxiety 
of patients with advanced CAD, the present study aims to address the following question: 
Is there a relationship between spiritual well-being and hope with health anxiety in pa-
tients with advanced CAD? 
2. Materials and Methods 
2.1. Participants and Procedure 
To investigate the predictive role of spiritual well-being and hope on health anxiety 
in CAD patients, this exploratory study used a quantitative, descriptive–correlational, 
cross-sectional design. One hundred and eight patients with coronary artery disease who 
were referred to hospitals and healthcare centers in Ardabil city (Iran) were recruited from 
October to December 2020. The eligibility criteria included the diagnosis of advanced 
CAD and an age range of 20 to 65 years. Exclusion criteria included history of attending 
meditation and yoga courses, experience of psychotherapy, a history of psychotic disor-
ders, a history of surgery in the last 6 months, death of a family member in the last year, 
or experience of divorce in the last year. A semi-structured interview was undertaken to 
assess these criteria. Based on this assessment, eight participants were not eligible to par-
ticipate in the study and were excluded. Of the sample, there were 65 males (64%) and 35 
females (36%). The patients ranged in age from 23 to 65 years with a mean (SD) age of 
44.53 years (7.62). The sample composition of participants’ highest level of education com-
pleted was 10.0% graduate school, 2.0% four years of college, 3.0% two years of college, 
39% high school, and 46% less than high school.  
The research team informed participants about the aims of the research and received 
written consent by them. Then, they filled out the questionnaires. The patients were in-
formed that the measures sought their actual feelings, thoughts, behaviors, and experi-
ences in daily life, and they were encouraged to fill them out honestly and completely. 
The instruments took the patients about 40 minutes to complete. The time interval for 
administering the questionnaire among patients was 4 weeks. 
2.2. Measures  
Spiritual Well-Being Scale (SWBS): Paloutzian and Ellison’s [24] SWBS is a general in-
dex of subjective well-being and perceived spiritual quality of life that includes 20 positive 
and negative items. Each item is scored on a six-point Likert scale, from “strongly disa-
gree” (score 1) to “strongly agree” (score 6). The SWBS includes two subscales: “religious 
well-being (RWB)” and “existential well-being (EWB)” [25,26]. The RWB subscale consists 
of 10 odd-numbered items, which assess the individual’s relationship with God (i.e., “I 
believe that God loves me and cares about me”). The EWB subscale consists of 10 even-
numbered items, which refer to the horizontal dimension of well-being about the world 
around us (i.e., “I don’t know who I am, where I came from, or where I’m going”). The 
total SWBS score is calculated by adding the RWB and EWB scores, which range from 20 
to 120. Higher scores indicate a higher level of well-being. Construct validity for the SWBS 
in an Iranian sample has been reported, and Cronbach alpha coefficients of 0.81, 0.84, and 
0.89 for the RWB, EWB, and SWBS, respectively [27]. In the present research, the Cronbach 
alpha coefficients for RWB, EWB, and SWBS were 0.81, 0.89, and 0.86, respectively. 
The Adult Hope Scale (AHS): Snyder et al. developed the Adult Hope Scale, which 
includes a 12-item measure of trait hope [28]. The AHS includes two subscales: “Agency” 
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and “Pathways”. Four items assess Agency (e.g., “I energetically pursue my goals”); 4 
items evaluate Pathways (e.g., “I can think of many ways to get out of a jam”); and four 
distractor items are included which are not scored. Agreement with each item is rated on 
an eight-point Likert scale from 1 (definitely false) to 8 (definitely true). The total AHS 
score is calculated by adding the Agency and Pathway scores, which range from 8 to 64, 
with higher scores indicating greater levels of hope. According to research conducted on 
undergraduate samples, the AHS has acceptable levels of internal consistency 
(Cronbach’s alpha = 0.74−0.84) [28] and temporal reliability (10- week test–retest reliability 
r = 0.76−0.82) [28]. Kermani et al. reported appropriate Cronbach’s alpha coefficients of 
0.77, 0.79, and 0.86 for the Agency, Pathway, and AHS, respectively, in an Iranian sample 
[29]. The Cronbach’s alpha coefficients for Agency, Pathway, and AHS in this study were 
0.83, 0.88, and 0.85, respectively. 
The Short Health Anxiety Inventory (SHAI): The Short Health Anxiety Inventory is an 
18-item self-report tool based on the cognitive model of health anxiety [30], which 
measures health anxiety over the past 6 months (e.g., “Thoughts of illness are so strong 
that I no longer even try to resist them”). Participants are asked to rate each item with four 
response options to examine cognitive and behavioral aspects of health anxiety (e.g., 0 = 
“I do not worry about my health;” 1 = “I occasionally worry about my health;” 2 = “I spend 
much of my time worrying about my health;” 3 = “I spend most of my time worrying 
about my health”). The total score can range from 0 to 54, with higher scores indicating 
greater severity of health anxiety. The SHAI has acceptable psychometric properties in-
cluding good internal consistency, test–retest reliability, and construct validity, and it is 
sensitive to treatment [31,32]. In an Iranian sample, Nargesi et al. reported an acceptable 
Cronbach’s alpha coefficient of 0.75 for the SHAI [33]. In the present study, the Cronbach’s 
alpha coefficient was excellent (alpha = 0.88). 
2.3. Ethical Consideration  
This research was approved by the Bioethics committee of University of Tabriz (The 
Ethical code: IR.ARUMS.REC.1400.144, Approved date: 1 November 2020). The study’s 
objective and procedure were explained to the patients by the research team. Participants 
were informed that their participation was completely voluntary and that they had the 
right to withdraw from the study at any time without penalty. The participants were told 
that their answers and scores would be kept anonymous. 
2.4. Data Analysis 
Statistical analysis was conducted using the SPSS 24.0 version program. Since less 
than 5% of data for any variable was missing, it was decided that the missing data could 
be overlooked without having a significant impact on the analyses [34]. For participants 
with missing data, pairwise deletion was utilized. Descriptive statistics were conducted 
with mean, standard deviation (SD), number (N), and percentage (%) for study variables. 
Skewness and kurtosis were used to check that variables were normally distributed (ac-
ceptable range: −2 to + 2; [35]). The Pearson correlation coefficient was used to examine 
the bivariate association of the research variables in the current study. In multivariate 
analysis, a 3-step hierarchical regression was run to evaluate the effects of hope and spir-
itual well-being on health anxiety after controlling for demographic variables (see Tables 
2 and 3). Sociodemographic variables (age, gender, and education status) were entered in 
Step 1 of the analysis, which was followed by the addition of the hope score in Step 2. 
Spiritual well-being was added in Step 3. Data including R2 ,R2 changes, F changes, stand-
ardized regression coefficients (β), and p values were provided for each step in the regres-
sion models. In addition, to check for multicollinearity, variance inflation factor values 
(VIF > 4; [36]) were used. The significance level for all tests was set at 0.05. 
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3. Results  
3.1. Correlations 
Correlations among variables are shown in Table 1. The results revealed that patients 
lower in total score of spiritual well-being generally had more health anxiety (r = −0.34, p 
< 0.01). As hypothesized, the religious spirituality (r = −0.40, p < 0.01) and existential spir-
ituality (r = −0.18) subscales were negatively correlated to the outcome variable of health 
anxiety.  
Table 1. Means, standard deviations, range, Cronbach alphas, and intercorrelation matrix of study variables. 
 Mean (SD) Range Skewness Kurtosis Alpha 1 2 3 4 5 6 7 8 9 10 
1. Health 




62.57(5.58) 29–73 −1.93 1.48 0.86 −0.34 ** 1         
3. Total hope 30.63 (5.29) 17–40 −0.32 −0.15 0.85 −0.44 ** 0.40 ** 1        
4. Religious 
spirituality 
32.25 (3.22) 14–38 −1.91 1.22 0.82 −0.40 ** 0.85 ** 0.42 ** 1       
5. Existential 
spirituality 
30.32 (3.33) 15–37 −1.76 1.02 0.89 −0.18 0.87 ** 0.26 ** 0.45 ** 1      
6. Agency 15.25 (3.06) 9–20 −0.55 −0.50 0.83 −0.48 ** 0.45 ** 0.95 ** 0.43 ** 0.35 ** 1     
7. Pathway 15.38 (2.54) 8–20 −0.15 0.10 0.88 −0.33 ** 0.28 ** 0.93 ** 0.35 ** 0.13 0.78 ** 1    
8. Age 44.53 (7.62) 23–65   - 0.06 −0.08 −0.07 −0.07 −0.07 −0.12 −0.00 1   
9. Gender - -   - −0.20 0.17 0.06 0.15 0.13 0.07 0.05 −0.29 ** 1  
10. Education - -   - −0.05 0.01 0.19 0.02 −0.00 0.19 0.16 0.11 −0.04 1 
** p < 0.01. 
Pearson’s correlation coefficient indicated that low scores on hope were significantly 
associated with more health anxiety (r = −0.44, p < 0.01). The agency subscale was nega-
tively and significantly related to health anxiety (r = −0.48, p < 0.01). Moreover, pathway 
scores were significantly correlated with health anxiety (r = −0.33, p < 0.01).  
The skewness and kurtosis showed that all variables were within acceptable ranges 
(−2 to +2; Byrne, 2010), confirming that the variables were normally distributed (Table 1). 
Examining variance inflation factor (VIF) values for all predictors across all linear regres-
sion models failed to reveal any multicollinear predictors (i.e., VIF > 4; Garson, 2012), in-
dicating that multicollinearity was not a concern for the independent variables used in 
this analysis (Tables 2 and 3). 
For study variables, the assumptions of multiple regression analysis were first tested. 
According to the Kolmogorov–Smirnov test results, the data are distributed normally. 
There was no multicollinearity, and the dependent and independent variables were line-
arly correlated. 
3.2. Hierarchical Multiple Regression Analysis for Hope and Spiritual Well-Being Subscales as 
Predictors of Health Anxiety 
The results of the multiple hierarchical regression analyses for hope and spiritual 
well-being subscales as predictors are provided in Table 2. The results indicated that at 
step 1, demographic variables explained 4% of the variance in health anxiety. After entry 
of agency and pathway at step 2, the total variance explained by the model was 33%. 
Therefore, agency and pathway explained 29% of the variance (R2 change). Adding reli-
gious spirituality and existential spirituality as predictors in step 3, the total variance in 
health anxiety explained was 39%. Therefore, religious spirituality and existential spirit-
uality explained 5% of the variance in outcome (R2 change), and the overall model was 
significant (F = 3.90, p < 0.05). In the final model, among the predictor variables, agency 
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(β= 0.58, p < 0.01) and religious spirituality (β = 0.28, p < 0.01) were shown to significantly 
negatively predict health anxiety level, but pathway and existential spirituality were not 
significant predictors. 
Table 2. Results of hierarchical multiple regressions for hope and spiritual well-being subscales as predictors of health 
anxiety. 
Outcomes Predictors B SE Beta T p R2 R2 Change F Change P VIF 
Health anxiety 
Step 1           
Age 0.010 0.099 0.011 0.099 0.921     1.09 
Gender −2.949 1.576 −0.197 −1.871 0.065 0.04 0.04 1.44 0.267 1.08 
Education status −0.445 0.630 −0.072 −0.706 0.482     1.01 
Step 2           
Age 0.083 0.085 0.089 0.981 0.329     1.13 
Gender −3.249 1.331 −0.217 −2.441 0.017     1.09 
Education status −1.127 0.542 −0.181 −2.077 0.041 0.33 0.29 20.15 0.000 1.05 
Agency −1.459 0.326 −0.622 −4.479 0.000     2.65 
Pathway −0.250 0.386 −0.089 −0.647 0.519     2.57 
Step 3           
Age 0.082 0.083 0.087 0.991 0.324     1.13 
Gender −3.606 1.308 −0.241 −2.758 0.007     1.11 
Education status −1.062 0.528 −0.171 −2.013 0.047     1.064 
Agency −1.357 0.348 −0.578 −3.898 0.000 0.39 0.05 3.90 0.000 3.219 
Pathway −0.405 0.390 −0.144 −1.039 0.302     2.791 
Religious 
spirituality 
−0.616 0.221 −0.277 −2.791 0.006     1.444 
Existential 
spirituality 
−0.213 0.211 −0.099 −1.007 0.316     1.418 
 
3.3. Hierarchical Multiple Regression Analysis for Total Scores of Hope and Spiritual Well-Being 
as Predictors of Health Anxiety 
The regression analysis for total scores of hope and spiritual well-being as predictors 
revealed at step 1, age, gender, and education status accounted for 4% of the variance. 
Adding hope as a predictor in step 2 explained 29% of the variation in health anxiety. 
Therefore, hope explained 25% of the variance in outcome (R2 change). After entry of spir-
itual well-being at step 3, the total variance explained by the model as a whole was 32%. 
Therefore, spiritual well-being explained only 3% of the variance (R2 change), and the 
overall model was significant (F = 4.44, p< 0.03). In the final model, both hope (β = 0.422, p 
< 0.01), and spiritual well-being (β = 0.20, p< 0.05) were significant predictors of health 
anxiety (see Table 3). 
Table 3. Results of hierarchical multiple regressions for total scores of hope and spiritual well-being as predictors of health 
anxiety. 
Outcomes Predictors B SE Beta T p R2 R2 Change F Change p VIF 
Health 
anxiety 
Step 1           
Age 0.010 0.099 0.011 0.099 0.921     1.09 
Gender −2.949 1.576 −0.197 −1.871 0.065 0.04 0.04 1.44 0.267 1.08 
Education status −0.445 0.630 −0.072 −0.706 0.482     1.01 
Step 2           
Age 0.045 0.086 0.048 0.525 0.601     1.10 
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Gender −3.335 1.369 −0.223 −2.436 0.017 0.29 0.25 31.94 0.000 1.09 
Education status −1.051 0.557 −0.169 −1.886 0.062     1.05 
Hope −0.686 0.121 0.506 −5.651 0.000     1.05 
Step 3           
Age 0.047 0.085 0.050 0.552 00.582     1.10 
Gender −3.752 1.359 −0.251 −2.760 0.007 0.32 0.03 4.44 0.039 1.11 
Education status −0.977 0.548 −0.157 −1.781 0.078     1.05 
Hope −0.572 0.131 −0.422 −4.373 0.000     1.26 
Spiritual well-
being 
−0.260 0.123 −0.202 −2.106 0.038     1.24 
 
4. Discussion  
The results showed that there is a significant negative relation between spiritual well-
being and health anxiety in patients with advanced CAD. Similarly, other researchers 
found the same results [18,19,37,38]. In the present study, religious spirituality was more 
strongly associated with diminished health anxiety than was existential spirituality. A 
possible explanation for this could be that existential well-being during CAD may be 
threatened as the patient questions the meaning and purpose of life and experiences di-
minished life satisfaction. A review of research evidence shows that spiritual well-being 
has a positive impact on health and is associated with a reduction in psychological symp-
toms associated with different diseases [39,40]. Regarding the explanation of this finding, 
it can be said that spiritual well-being is a basic component of the well-being dimensions; 
other dimensions of well-being include physical, mental, and social well-being. Spiritual 
well-being is a determining and influential factor that affects the way people deal with 
hardships and difficulties; it creates emotions such as happiness and hope by creating 
meaning, a sense of purpose and self-efficacy, and a positive mental space [41]. As a result, 
it can reduce health anxiety in patients with CAD.  
Spiritual well-being is considered as a protective factor in promoting health and pre-
venting diseases. Religious well-being provides social support for individuals through 
factors such as forging close ties with members of religious groups, establishing deep 
friendships with these members, and engaging in altruistic behaviors, thereby reducing 
stress and anxiety in individuals [42]. CAD patients with high religious well-being may 
cope with life challenges through reliance on the support and the guidance of God, and 
religious belief helps them overcome their problems. It is noteworthy that these types of 
coping behaviors and religious lifestyle lead to a reduction in psychological symptoms, 
such as anxiety in patients. Religious and spiritual beliefs play a very important role in 
shaping the culture of the Iranian people. In a study on a Persian sample, for example, it 
was shown that spirituality is a fundamental element in elderly individuals’ lives that 
helps them adapt to daily living conditions [43]. Therefore, the findings of the present 
study on the predictive role of spiritual well-being on the health anxiety of patients with 
CAD can also be due to these cultural aspects. In general, it can be said that spiritual well-
being acts as a protective shield against health anxiety in patients with CAD and helps 
these patients overcome emotional distress. 
Notwithstanding, the current findings indicated that hope had greater explanatory 
power in predicting health anxiety than did spiritual well-being as more of the variance 
in health anxiety was explained by hope subscales and total hope scores. The dimension 
of Agency was more predictive of reduced health anxiety than was the Pathway dimen-
sion of hope. Being motivated to take direct action to pursue goals was more important in 
giving hope than the actual pathway to achieving these goals. For patients with CAD tak-
ing the first step in cardiac rehabilitation, with a hopeful attitude that any obstacles can 
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be overcome, may be more important than pursuing a number of alternative pathways to 
recovery.  
Our results on the significant negative relation between hope and health anxiety in 
patients with CAD is consistent with those of other researchers [18–20], which reported a 
significant relation between optimism and hope with reduced anxiety among advanced 
CAD patients. One study indicated that people with higher scores on the hope scale show 
less symptoms of depression and anxiety and have a better quality of life [44]. Moreover, 
anxiety was shown to be lower in people with higher levels of hope [45]. Similarly, it was 
suggested that health anxiety decreases with increasing hope [46]. Hope can be considered 
as an active and dynamic state of existential coping strategy among people with life-
threatening illness [47]. Hope is a strong adaptation mechanism in patients with chronic 
illness, and hopeful people are better able to cope with the crisis and psychological symp-
toms such as anxiety. As confirmed by several studies, hope is a powerful source of coping 
with anxiety and stress. Hope is closely related to other positive psychological constructs, 
such as self-efficacy and optimism [48]. It has also been shown to be associated with pro-
moting resilience and recovery from emotional disorders such as anxiety [48]. Therefore, 
it can be said that hope acts as a strong source of coping with health anxiety in patients 
with CAD and reduces health anxiety in these patients by potentially improving self-effi-
cacy, optimism, and other positive psychological constructs.  
5. Limitations, Strengths, and Future Directions 
The present study had some limitations that should be considered in generalizing 
and interpreting the results. Since the present research used a descriptive–correlation 
method, the relationships obtained from it cannot be considered as cause and effect. In 
addition, the study population, which included CAD patients, limits the generalization of 
results to other patients. However, despite the mentioned limitations, the present study 
enriched the research literature on the role of spiritual and psychological factors affecting 
the health anxiety of patients with CAD. According to the results of the present study, 
there is a need for health professionals to consider the therapeutic aspects of spiritual well-
being and hope in order to reduce the level of health anxiety in patients with CAD. 
Future research may wish to consider other means of attaining spiritual well-being 
such as engaging in meditation or yoga, on the health anxiety of patients with CAD. We 
were particularly interested in religious well-being and existential well-being as measured 
by the Spiritual Well-Being Scale. We acknowledge that yoga and meditation may be part 
of an individual’s spirituality, and for this reason, patients with recent practice of yoga or 
meditation were excluded. Future studies may also wish to explore gender differences in 
spiritual well-being and any effect this may have on health anxiety. 
6. Conclusions 
In general, it can be concluded that spiritual well-being and hope give meaning to 
life and lead to a positive change of attitude, increasing psychological capital and self-
confidence in the life of patients with CAD, and thus are effective in reducing health anx-
iety in these individuals. 
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